JOSEF H VON RICKENBACH
CIK 1007706 · Chairman & CEO · last filed 2026-05-28
JOSEF H VON RICKENBACH is a Chairman & CEO who has filed 102 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $49.6K of RNTX on May 28, 2026. Across all open-market trades the lifetime net is −$28.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $55.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$55.6K
4
102
-$28.10M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNTX | Director | 58,014 | $0.96 | $55.6K | $49.6K | 2 | 2026-05-28 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | 445,460 | $2.11 | $939.9K | $400.3K | 13 | 2024-12-06 |
| Virgin Orbit Holdings, Inc. (VORBW) Delisted | 125,000 | $0.01 | $875 | $0 | 1 | 2022-01-03 | |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Chairman & CEO | 503,329 | — | — | -$28.55M | 85 | 2017-09-18 |
Recent Filings
102 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | RNTX | Buy (P) | +47,060 | $49.6K | EDGAR |
| 2025-07-23 | RNTX | Grant (A) | — | $0 | EDGAR |
| 2024-12-06 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-22 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-10 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-01 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-03 | Virgin Orbit Holdings, Inc. (VORBW) Delisted | Grant (A) | +125,000 | $1.25M | EDGAR |
| 2021-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |